Published in Blood Weekly, July 29th, 2004
The company is a biopharmaceutical company that specializes in immune-based therapy in HIV and multiple sclerosis (MS). The data were presented at the 14th meeting of the European Neurological Society (ENS) in Barcelona, Spain
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.